• Using Predictive Analytics to Enhance Customer Interaction

    Feature Articles by on March 17th, 2017

    Getting data to help us better interact with our customers is something we all strive to do. Historically, the pharmaceutical industry has used the abundant data it collects on doctor prescribing, patient claims, outlet sales, rep calls, marketing promotional spend, managed care formulary—and the list goes on to address business problems centered on brand performance […]

  • The Intervention-Environment Matrix for Predictive Analytics

    Feature Articles by on March 17th, 2017

    Predictive analytics efforts can significantly impact commercial success by optimizing sales and marketing efforts. Commercial leaders experienced in the utilization of predictive analytics will have developed a good sense of where predictive analytic efforts can be deployed most effectively and with the highest probability of success. For organizations with little experience in this area, however, […]

  • Navigating the Challenges of Prescription Affordability

    Feature Articles by on March 17th, 2017

    Regardless of the future of the ACA, prescription affordability has been and will continue to be a significant issue in American healthcare. Looking ahead, two important players in the healthcare mix—payers and the new Trump administration—will likely exert more pressure on pharmaceutical companies to lower the cost of branded medications. Just as important, physicians and […]

  • Meeting the Targets of Triple Aim

    Feature Articles by and on March 17th, 2017

    For quite some time healthcare costs have stood firmly in the crosshairs of lawmakers, care advocates, and cash-strapped patients—and not without reason. Obamacare was intended to dampen the growth of healthcare costs, while increasing quality of care and expanding access. However, at 28% of the 2017 U.S. federal budget, healthcare is the largest expense, nearly […]

  • Risk/Outcomes Contracting Has Finally Arrived

    Feature Articles by on February 24th, 2017

    In our organization’s payer market research, we generally find pharmacy and medical directors respond to proposed risk- or outcomes-based contracting with muted interest. The reasons often include cost of contract management, lack of internal staff and infrastructure to extract and report the data, and inconsistent data availability across their membership. Among insurers and networks, electronic […]

  • Avoid the Price Crisis

    Feature Articles by on February 24th, 2017

    Reputational crisis. This is the best expression to describe the worsening relationship between the biopharmaceutical industry and the very people it seeks to serve. Today, companies that make medicines to save or improve peoples’ lives are less respected than law firms and oil companies.1 One study even shows that the number of Americans who believe […]

  • Making Step Therapy Work for Patients, Providers, and Payers

    Feature Articles by on February 24th, 2017

    The use of step therapy protocols by payers to manage pharmacy costs has increased significantly over the past several years. According to Health Strategies Group, in 2015, 39% of health plans used step therapy in at least 12 classes of medications—an increase of 35% over the prior year. At its core, step therapy is about […]

  • Overcoming the Challenges of Step Therapy

    Feature Articles by on February 24th, 2017

    Step therapy, or “fail first” as it is sometimes called, requires patients to first attempt treatment with one drug before the payer will allow coverage of the treatment initially prescribed by the physician. Payers implement these protocols as a way to manage costs by first steering a patient to a generic or formulary-preferred drug. This […]

  • Healthcare 2017: A New Day is Dawning

    The results of the recent presidential election caught many by surprise, including much of the healthcare industry. Given her track record as First Lady, Senator, and Secretary of State, many felt they knew what to expect from a Clinton administration and were building plans for it. However, a Trump win has left many wondering what […]

  • Is Your Online Audience Even Real?

    Feature Articles by on January 18th, 2017

    The short answer is “Yes.” Some of it. The harder question is what portion of it is real—that is, humans reading real content and viewing your digital ads. In the last five years, digital fraud rose dramatically alongside the rapid growth of programmatic “ad tech.” The intersection of digital ad fraud and the pharmaceutical and […]

  • Innovators 2016: Companies

    Feature Articles by on December 21st, 2016

    PM360’s Innovations Issue, established five years ago, serves as a comprehensive guide to our readers, providing a glimpse at the year’s most cutting-edge: Companies, Divisions, Startups, Products, Services, and Strategies. Here are our picks for the most innovative companies of 2016, which include any organization developing new ways to push the industry forward 81qd ADM […]

  • How Companion Devices are Arming the Boon in Personalized Medicine

    Feature Articles by on December 21st, 2016

    The concept of personalized medicine has been around for a long time. We know that similar symptoms present across a variety of different illnesses, and that treatments that work well in some patients do not work well in others. What’s new are the advances across technology and science that allow researchers and doctors to monitor […]

  • Innovators 2016: Services

    Feature Articles by on December 21st, 2016

    PM360’s Innovations Issue, established five years ago, serves as a comprehensive guide to our readers, providing a glimpse at the year’s most cutting-edge: Companies, Divisions, Startups, Products, Services, and Strategies. Here are our picks for the most innovative services of 2016, which include compelling offerings that help the industry tackle new challenges. Advocacy Launch: Discovery […]

Back to top